KENDALL HASSIG: Open Payments
NPI 1548695398 · FRASER, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,048 in 63 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $461 · 2025 $1,048
Food & beverage: $1,048
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $302 |
| ABBVIE INC. | 22 | $198 |
| E.R. Squibb & Sons, L.L.C. | 4 | $148 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| Corium, LLC | 2 | $55 |
| Alkermes, Inc. | 3 | $54 |
| Neurocrine BioSciences, Inc. | 2 | $48 |
| Lundbeck LLC | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $38 |
Products named: CAPLYTA, VRAYLAR, COBENFY, REXULTI, FANAPT, Azstarys, LYBALVI, INGREZZA.
Industry payments across MI — which companies pay providers there.
